Ten patients (8 males, 2 females) suffering from peripheral obliterative arterial disease (POAD) underwent intravenous administration of Iloprost (2-4 ng/kg/min); each infusion lasted 20 minutes. Assessment of peripheral haemodynamics of haemorheological and metabolic effects and evaluation of variations in tissue O2 transport induced by Iloprost were performed before, at the end, and at regular intervals after the infusion. The i.v. infusion at the dose of 4 ng/kg/min did not induce any variations in regional blood flow. Oxygen extraction per cent (whole lower limb) decreased. Intraerythrocyte 2,3DPG increased, and contemporarily p50 increased indicating a reduction in O2 affinity of haemoglobin; a decrease in blood viscosity associated wi...
Background Iloprost, a prostacyclin analogue, is used in the treatment of peripheral arterial occlu...
The effect of intravenous iloprost treatment (median rate: 1.6; range 1-2 ng/kg/min; 6 h daily over ...
OBJECTIVE: To evaluate the effects of iloprost infusion on the microcirculation in patients sufferin...
Ten patients (8 males, 2 females) suffering from peripheral obliterative arterial disease (POAD) und...
BACKGROUND: Iloprost therapy for severe peripheral obstructive arterial disease (POAD) has demonstra...
Background: In peripheral vascular disease (PVD), impaired blood viscosity (BV) plays a major role i...
Background: In peripheral vascular disease (PVD), impaired blood viscosity (BV) plays a major role i...
Four uremic patients with advanced peripheral arterial occlusive disease (PAOD) of lower limbs causi...
From September 1999 to September 2001 we treated 45 patients affected with peripheral occlusive arte...
From September 1999 to September 2001 we treated 45 patients affected with peripheral occlusive arte...
Four uremic patients with advanced peripheral arterial occlusive disease (PAOD) of lower limbs cau...
Background Iloprost, a prostacyclin analogue, is used in the treatment of peripheral arterial occlu...
Abstract\u2014Previous studies demonstrated that iloprost improves the peripheral circulatio...
Background Iloprost, a prostacyclin analogue, is used in the treatment of peripheral arterial occlu...
The effect of intravenous iloprost treatment (median rate: 1.6; range 1-2 ng/kg/min; 6 h daily over ...
Background Iloprost, a prostacyclin analogue, is used in the treatment of peripheral arterial occlu...
The effect of intravenous iloprost treatment (median rate: 1.6; range 1-2 ng/kg/min; 6 h daily over ...
OBJECTIVE: To evaluate the effects of iloprost infusion on the microcirculation in patients sufferin...
Ten patients (8 males, 2 females) suffering from peripheral obliterative arterial disease (POAD) und...
BACKGROUND: Iloprost therapy for severe peripheral obstructive arterial disease (POAD) has demonstra...
Background: In peripheral vascular disease (PVD), impaired blood viscosity (BV) plays a major role i...
Background: In peripheral vascular disease (PVD), impaired blood viscosity (BV) plays a major role i...
Four uremic patients with advanced peripheral arterial occlusive disease (PAOD) of lower limbs causi...
From September 1999 to September 2001 we treated 45 patients affected with peripheral occlusive arte...
From September 1999 to September 2001 we treated 45 patients affected with peripheral occlusive arte...
Four uremic patients with advanced peripheral arterial occlusive disease (PAOD) of lower limbs cau...
Background Iloprost, a prostacyclin analogue, is used in the treatment of peripheral arterial occlu...
Abstract\u2014Previous studies demonstrated that iloprost improves the peripheral circulatio...
Background Iloprost, a prostacyclin analogue, is used in the treatment of peripheral arterial occlu...
The effect of intravenous iloprost treatment (median rate: 1.6; range 1-2 ng/kg/min; 6 h daily over ...
Background Iloprost, a prostacyclin analogue, is used in the treatment of peripheral arterial occlu...
The effect of intravenous iloprost treatment (median rate: 1.6; range 1-2 ng/kg/min; 6 h daily over ...
OBJECTIVE: To evaluate the effects of iloprost infusion on the microcirculation in patients sufferin...